Opinion

Video

Progress in Immunotherapy and Precision Medicine: Key Insights from JTCC at ASH 2024

Author(s):

Andre Goy, MD, MS

Andre Goy, MD, discusses how progress in immunotherapy and precision medicine at ASH 2024 is shaping the future of cancer treatment, with key insights from the JTCC highlighting emerging therapies and their potential to improve patient outcomes through personalized approaches.

Related Videos
2 experts in this video
2 experts in this video
1 expert in this video
1 expert in this video
1 expert in this video
Related Content
Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment
September 15th 2021

Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment